Beliefs and behaviour about smoking among inflammatory bowel disease patients

Saadoune, Nafissa; Peyrin–Biroulet, Laurent; Baumann, Cédric; Bigard, Marc‐André; Wirth, N.; Martinet, Yves; Peyrin-Biroulet, Carina

doi:10.1097/meg.0000000000000371

Cited by 17 publications

(18 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…16,18 Studies in non-IBD populations have found that smoking initiation is more likely when there is a perceived short-term benefit, despite acceptance of short-and long-term risks. Furthermore, we found no evidence that smoking cessation impacts adversely on subsequent clinical outcomes.…”

Section: Discussionmentioning

confidence: 99%

“…4 However, more recent studies have not supported this finding. 16 The wider health benefits of smoking cessation are beyond dispute 17 but its impact on clinical outcomes in UC is poorly understood. 14 These findings were at odds with a prior meta-analysis, using different inclusion criteria, which found smoking to be associated with reduced risk of colectomy (OR 0.55, 95% CI 0.33-0.91).…”

Section: Introductionmentioning

confidence: 99%

“…The few studies evaluating the impact of smoking cessation on disease outcomes in UC are inconsistent. 16 Clinicians may also sometimes recommend smoking as a therapeutic approach where conventional therapies have failed. Yet the same study found no difference in the rates of corticosteroid use, hospitalisation or colectomy between persistent smokers and quitters.…”

Section: Introductionmentioning

confidence: 99%

“…15 This has led to a belief that smoking may be beneficial in UC and some patients report that they smoke to ameliorate their disease. 16 The wider health benefits of smoking cessation are beyond dispute 17 but its impact on clinical outcomes in UC is poorly understood. The few studies evaluating the impact of smoking cessation on disease outcomes in UC are inconsistent.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population‐based study

Blackwell

Saxena

Alexakis

et al. 2019

Aliment Pharmacol Ther

View full text Add to dashboard Cite

Background:Smokers are less likely to develop ulcerative colitis (UC) but the impact of smoking and subsequent cessation on clinical outcomes in UC is unclear. Aim:To evaluate the effect of smoking status and smoking cessation on disease outcomes.Methods: Using a nationally representative clinical research database, we identified incident cases of UC during 2005-2016. Patients were grouped as never-smokers, ex-smokers and smokers based on smoking status recorded in the 2 years preceding UC diagnosis. We defined subgroups of persistent smokers and smokers who quit within 2 years after diagnosis. We compared the rates of overall corticosteroid use, corticosteroid-requiring flares, corticosteroid dependency, thiopurine use, hospitalisation and colectomy between these groups. Results:We identified 6754 patients with a new diagnosis of UC over the study period with data on smoking status, of whom 878 were smokers at diagnosis. Smokers had a similar risk of corticosteroid-requiring flares (OR 1.16, 95% CI 0.92-1.25), thiopurine use (HR 0.84, 95% CI 0.62-1.14), corticosteroid dependency (HR 0.85, 95% CI 0.60-1.11), hospitalisation (HR 0.92, 95% CI 0.72-1.18) and colectomy (HR 0.78, 95% CI 0.50-1.21) in comparison with never-smokers. Rates of flares, thiopurine use, corticosteroid dependency, hospitalisation and colectomy were not significantly different between persistent smokers and those who quit smoking after a diagnosis of UC. Conclusions:Smokers and never-smokers with UC have similar outcomes with respect to flares, thiopurine use, corticosteroid dependency, hospitalisation and colectomy. Smoking cessation was not associated with worse disease course. The risks associated with smoking outweigh any benefits. UC patients should be counselled against smoking. | 557 BLACKWELL Et AL.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population‐based study

Blackwell

Saxena

Alexakis

et al. 2019

Aliment Pharmacol Ther

View full text Add to dashboard Cite

show abstract

“…Most patients are not aware of the effects of smoking on their disease activity. In a questionnaire study, three-quarters of smokers knew that tobacco was not beneficial for their CD, whereas all UC patients were aware that smoking had a beneficial effect [51]. The intent to quit smoking was superior in informed patients compared with those who were uninformed.…”

Section: Introductionmentioning

confidence: 99%

Care of inflammatory bowel disease patients in remission

Subramanian

Triadafilopoulos

2016

Gastroenterol. Rep.

View full text Add to dashboard Cite

Inflammatory bowel disease (IBD) comprises two distinct conditions: ulcerative colitis and Crohn’s disease, both of which are chronic, relapsing disorders carrying significant morbidity, mortality and healthcare costs. With growing attention to coordinated healthcare for patients with chronic systemic diseases, this review focuses on the care of IBD patients in remission, their concerns, quality of life, follow-up, the role of primary care physicians and the IBD-specific aspects of long-term care. We did an extensive PubMed search for articles pertaining to IBD patients in remission and, along with the authors’ experience, formulated a comprehensive review. The difficulties faced by IBD patients in remission include but are not limited to education and employment concerns, psychosocial issues, problems related to health insurance, nutrition, fertility and infections. This review also addresses newer treatment modalities, the debatable effects of smoking on IBD and the importance of vaccination. IBD in remission can be a challenge due to its multifaceted nature; however, with a coordinated approach by gastroenterologists and other involved practitioners, several of these issues can be addressed.

show abstract

Communication of alcohol and smoking lifestyle advice to the gastroenterological patient

Spence

Khasawneh

Allen

et al. 2017

Best Practice & Research Clinical Gastroenterology

View full text Add to dashboard Cite

Beliefs and behaviour about smoking among inflammatory bowel disease patients

Abstract: The majority of IBD patients are unaware of the effects of tobacco on their disease. Better information through a therapeutic education programme should be systematically recommended in IBD.

Cited by 17 publications

References 29 publications

The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population‐based study

The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population‐based study

Care of inflammatory bowel disease patients in remission

Communication of alcohol and smoking lifestyle advice to the gastroenterological patient

Contact Info

Product

Resources

About